platinum has been researched along with Bile Duct Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 6 (85.71) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, DH; Arora, M; Babiker, H; Baker, A; Barrett, M; Barro, O; Bekaii-Saab, TS; Bogenberger, J; Borad, MJ; Botrus, G; Boyle, AWR; Buetow, K; Dumbauld, C; Elliott, N; Gores, GJ; Inabinett, SR; Jones, JC; Majeed, U; Mansfield, A; Meurice, N; Mody, K; Nagalo, B; Petit, J; Smoot, R; Sonbol, MB; Starr, JS; Uson Junior, PLS; Wylie, N; Yin, J; Zhou, Y | 1 |
| Kim, H; Kim, JY; Park, KU | 1 |
| Kanai, M; Kondo, T; Matsumori, T; Murakami, H; Muto, M; Nagai, K; Sunami, T; Uchida, Y; Uza, N; Yamada, A; Yamada, T; Yokode, M | 1 |
| Ahn, CS; Chae, H; Chang, HM; Hong, SM; Hwang, DW; Hwang, S; Jang, SJ; Jeong, JH; Kim, D; Kim, KH; Kim, KP; Kim, SC; Kim, TW; Lee, JH; Lee, SS; Park, DH; Ryoo, BY; Song, GW; Song, TJ; Yoo, C | 1 |
| Borbath, I; Delaunoit, T; Demols, A; Goemine, JC; Holbrechts, S; Houbiers, G; Laurent, S; Marechal, R; Paesmans, M; Peeters, M; Van den Eynde, M; Van Laethem, JL | 1 |
| Aprile, G; Brandi, G; Brieau, B; Casadei-Gardini, A; Dahan, L; Evesque, L; Filippi, R; Le Sourd, S; Lièvre, A; Lonardi, S; Meurisse, A; Neuzillet, C; Pointet, AL; Rousseau, B; Scartozzi, M; Silvestris, N; Tougeron, D; Vernerey, D; Vienot, A; Vivaldi, C | 1 |
| Byeon, S; Hong, JY; Jang, KT; Kang, WK; Kim, H; Kim, J; Kim, ST; Lee, J; Lim, HY; Park, JO; Park, SH; Park, YS | 1 |
1 trial(s) available for platinum and Bile Duct Neoplasms
| Article | Year |
|---|---|
Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Deoxycytidine; Double-Blind Method; Gemcitabine; Humans; Phenylurea Compounds; Platinum; Pyridines; Treatment Outcome | 2020 |
6 other study(ies) available for platinum and Bile Duct Neoplasms
| Article | Year |
|---|---|
Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Cholangiocarcinoma; Circulating Tumor DNA; Cisplatin; Clone Cells; Gene Frequency; Humans; Platinum; Retrospective Studies | 2022 |
Clinical Implications of BRCA Mutations in Advanced Biliary Tract Cancer.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Cholangiocarcinoma; Female; Humans; Male; Mutation; Platinum | 2023 |
Exceptional Response of Pancreatic Acinar Cell Carcinoma and Bile Duct Cancer to Platinum-Based Chemotherapy in a Family With a Germline BRCA2 Variant.
Topics: Adult; Bile Duct Neoplasms; BRCA1 Protein; BRCA2 Protein; Carcinoma, Acinar Cell; Genetic Predisposition to Disease; Germ Cells; Germ-Line Mutation; Humans; Male; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Platinum | 2022 |
Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Biliary Tract Surgical Procedures; Biomarkers, Tumor; Cholangiocarcinoma; Combined Modality Therapy; DNA Damage; DNA Repair Enzymes; Exome Sequencing; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; High-Throughput Nucleotide Sequencing; Humans; Male; Middle Aged; Mutation; Platinum; Prognosis; Retrospective Studies; Survival Rate | 2019 |
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Capecitabine; Female; Fluorouracil; France; Humans; Irinotecan; Italy; Male; Middle Aged; Platinum; Prospective Studies; Pyrimidines; Retrospective Studies; Survival Analysis; Treatment Outcome | 2020 |
Programmed Death Ligand 1 Expression as a Prognostic Marker in Patients with Advanced Biliary Tract Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Bile Duct Neoplasms; Biomarkers, Tumor; Cholangiocarcinoma; Deoxycytidine; Female; Gallbladder Neoplasms; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Palliative Care; Platinum; Prognosis; Survival Analysis; Treatment Outcome | 2021 |